Adjuvant doxycycline to enhance anti-amyloid effects: Results from the dual phase 2 trial

BACKGROUND: Although, doxycycline use is associated with improved outcomes in amyloidosis in retrospective studies, evidence from clinical trials is limited. METHODS: This phase 2 trial of doxycycline (clinicaltrials.gov: NCT02207556) in newly diagnosed light chain (AL) amyloidosis enrolled 25 patie...

Descripción completa

Detalles Bibliográficos
Autores principales: D'Souza, Anita, Szabo, Aniko, Flynn, Kathryn E., Dhakal, Binod, Chhabra, Saurabh, Pasquini, Marcelo C., Weihrauch, Dorothee, Hari, Parameswaran N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Research paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7280748/
https://www.ncbi.nlm.nih.gov/pubmed/32529175
http://dx.doi.org/10.1016/j.eclinm.2020.100361

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7280748/
https://www.ncbi.nlm.nih.gov/pubmed/32529175
http://dx.doi.org/10.1016/j.eclinm.2020.100361

Ejemplares similares